Neuronetics announced a collaboration agreement with Compass, leading to the FDA clearance of Spravato and the acquisition of Greenbrook TMS.
1 report, 1 independent
Updated Jul 20
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Neuronetics announced a collaboration agreement with Compass, leading to the FDA clearance of Spravato and the acquisition of Greenbrook TMS.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Benzinga
American news channel
-
Compass
Credit institution that offers online loans, personal financing, and other financial products.
- FDA
Related events
- Benzinga is reporting on companies that are listed on the Nasdaq stock exchange.
- Benzinga reported on the financial performance of Salesforce, Inc. on May 27, 2026.
- Benzinga reported on the financial performance of UnitedHealth Group, while MarketBeat aggregated consensus ratings and target prices.
- Renaissance Technologies raised its position in Rockwell Medical, while Benzinga and HC Wainwright reported on stock ratings.